Revolution Medicines (RVMD) Net Margin (2019 - 2025)
Historic Net Margin for Revolution Medicines (RVMD) over the last 6 years, with Q3 2025 value amounting to 2670.69%.
- Revolution Medicines' Net Margin changed N/A to 2670.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 8408.98%, marking a year-over-year increase of 848322900.0%. This contributed to the annual value of 3768.28% for FY2023, which is 30653300.0% down from last year.
- According to the latest figures from Q3 2025, Revolution Medicines' Net Margin is 2670.69%.
- In the past 5 years, Revolution Medicines' Net Margin ranged from a high of 2670.69% in Q3 2025 and a low of 21770.49% during Q4 2023
- Its 4-year average for Net Margin is 2739.05%, with a median of 716.15% in 2022.
- In the last 5 years, Revolution Medicines' Net Margin soared by 26233400bps in 2022 and then plummeted by -214018800bps in 2023.
- Quarter analysis of 4 years shows Revolution Medicines' Net Margin stood at 556.83% in 2021, then soared by 34bps to 368.6% in 2022, then crashed by -5806bps to 21770.49% in 2023, then surged by 112bps to 2670.69% in 2025.
- Its Net Margin stands at 2670.69% for Q3 2025, versus 21770.49% for Q4 2023 and 2570.55% for Q2 2023.